Effect of dapagliflozin on blood and breath ketones during supervised insulin withdrawal in adults with type 1 diabetes: A randomized crossover trial
In adults with type 1 diabetes undergoing supervised insulin withdrawal, dapagliflozin treatment compared to usual care was associated with greater blood and breath ketone concentrations in the absence of significant hyperglycaemia.
Authors
- Kai E. Jones (ORCID: https://orcid.org/0000-0002-6751-4765)
- Alexis M. McKee (ORCID: https://orcid.org/0000-0001-5382-0203)
- Samantha E. Adamson (ORCID: https://orcid.org/0000-0002-9984-7046)
- Alexander M. Markov (ORCID: https://orcid.org/0000-0002-6644-4099)
- Petra Krutilova (ORCID: https://orcid.org/0000-0002-6174-1588)
- Kathryn L. Bohnert (ORCID: https://orcid.org/0000-0003-2612-6771)
- Janet B. McGill (ORCID: https://orcid.org/0000-0002-6228-6521)
- Maamoun Salam (ORCID: https://orcid.org/0000-0002-9789-6389)
- Max C. Petersen (ORCID: https://orcid.org/0000-0001-8646-2377)
Institutions
- Washington University in St. Louis (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1111/dom.16324
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health